Our medical affairs team is at your service

We are empowering mental health treatment by advancing the science and education of pharmacogenomics. And we’re here to help you help your patients.

Superior customer support

In a survey conducted between July 31, 2023 to December 8, 2023, 98% of GeneSight-prescribing clinicians surveyed were satisfied or very satisfied with their interaction with the Medical Affairs team, specifically in the areas of professionalism, knowledge, clear communication, and understanding your needs.

Professionalism: 100%
Knowledge: 96%
Clear communication: 98%
Understanding your needs: 94%

Your partner in pharmacogenomics

The Medical Affairs team consists of highly-educated experts with advanced degrees who serve as a clinical and scientific resource for healthcare providers like you. Our team is available to deliver complimentary report consultations on the interpretation of specific GeneSight reports, provide evidence-based education to increase awareness and knowledge of PGx testing, direct you to evidence-based clinical resources, and more.

When scheduling your free consultation please include your name, NPI, and any specific questions you have.

Schedule your free consultation

Our Medical Affairs team members are leading contributors in the precision medicine space

The team collaborates with clinicians and researchers on potential investigator-initiated clinical trials, and gathers feedback on the GeneSight Psychotropic test through two-way scientific exchange with stakeholders and clinicians.

Meet the team

Leadership

The Myriad Medical Affairs leadership is responsible for providing scientific and clinical support for GeneSight to stakeholders and practitioners in the healthcare ecosystem.

Dr. Holly Johnson

PhD in Neuroscience

Director of Medical Affairs

Dr. Johnson oversees medical strategy development and execution, evidence generation, and medical content creation to advance the science and education of psychiatric pharmacogenomics.

Dr. Rachael Hart Earls

PhD in Molecular Neuroscience

Medical Science Liaison Manager

Dr. Earls helps support pharmacogenomic education efforts, medical strategy, and evidence generation to advance the science of psychiatric pharmacogenomics.

Medical science liaisons

Medical Science Liaisons (MSLs) are field-based members of the medical affairs team that cover distinct geographies across the United States. The MSL team provides in-person educational support on pharmacogenomics to healthcare providers.

Dr. Ryan Griggs

PhD in Neurophysiology

Senior Medical Science Liaison

Dr. Ryan Griggs strives to improve mental health care by supporting psychiatric pharmacogenomic testing.

Dr. Samantha Socco

PharmD

Senior Medical Science Liaison

Dr. Samantha Socco has specialized residency training in clinical pharmacy and pharmacogenomics and has a strong interest in pharmacogenomics implementation and the advancement of pharmacogenomics in psychiatric care.

Dr. Melissa Dyer

PhD in Neuroscience

Senior Medical Science Liaison

Dr. Melissa Dyer has a strong interest in the application of precision medicine to improve patient outcomes.

Dr. Morgan Freas

PharmD

Executive Medical Science Liaison

Dr. Morgan Freas has a robust interest in advancing pharmacist involvement in pharmacogenomic testing through medication management.

Questions?

Connect with the Myriad Mental Health Medical Affairs Team

medinfo@genesight.com Call 855.891.9415

Medical information liaisons

Medical information liaisons (MILs) are headquarter-based members of the medical affairs team that are on-call Monday-Friday 8:00 am-6:00 pm EST. MILs can answer any inquiries related to mental health or pharmacogenomics for healthcare providers or patients and create educational collateral to increase awareness and knowledge of pharmacogenomic testing.

Dr. Kale Hanavan